Rosa Vladimir, Chaar Cassius Iyad Ochoa, Espitia Olivier, Otalora Sonia, López-Jiménez Luciano, Ruiz-Sada Pablo, Verhamme Peter, Muñoz-Torrero Juan Francisco Sánchez, Marchena Pablo Javier, Monreal Manuel
Department of Internal Medicine, Hospital Universitario Virgen de Arrixaca, Murcia, Spain.
Department Surgery, Division of Vascular Surgery and Endovascular Therapy, Yale University School of Medicine, New Haven, CT, USA.
Thromb Res. 2022 May;213:65-70. doi: 10.1016/j.thromres.2021.12.030. Epub 2022 Jan 4.
Upper extremity deep vein thrombosis (UEDVT) related to thoracic outlet syndrome (TOS) is rare, and the literature is limited to institutional case series.
We used data from the RIETE Registry to compare outcomes (recurrences, major bleeding and signs and symptoms of post-thrombotic [PTS] syndrome) in patients with UEDVT and TOS undergoing first rib resection vs. those not undergoing surgery.
From March 2001 to March 2021, there were 4214 patients with UEDVT, of whom 209 (4.96%) had TOS. Of these, 55 (26%) underwent first rib resection. Patients with TOS were younger and less likely to have comorbidities than those without TOS. There were no differences between patients with TOS undergoing surgery and those who did not. During anticoagulation, patients with TOS had a non-statistically significant lower rate of VTE recurrences than those without TOS (hazard ratio [HR]: 0.46; 95%CI: 0.14-1.12) and a lower bleeding rate (HR: 0.16; 95%CI: 0.01-0.83). No patient with TOS developed pulmonary embolism or died. Patients with TOS undergoing surgery had fewer PTS symptoms (odds ratio [OR]: 0.21; 95%CI: 0.06-0.68) or signs (OR: 0.11; 95%CI: 0.02-0.42) after one year than patients who did not have surgery. At two years, the differences in symptoms (OR: 0.25; 95%CI: 0.06-0.94) and signs (OR: 0.04; 95%CI: 0.002-0.33) persisted.
Patients with UEDVT and TOS were younger and had less comorbidities than those without. Surgical resection of the first rib was associated with a lower proportion of patients developing PTS one and two years later.
与胸廓出口综合征(TOS)相关的上肢深静脉血栓形成(UEDVT)较为罕见,文献仅限于机构病例系列报道。
我们使用RIETE注册中心的数据,比较接受第一肋切除术的UEDVT合并TOS患者与未接受手术患者的预后(复发、大出血和血栓后综合征[PTS]的体征和症状)。
2001年3月至2021年3月,共有4214例UEDVT患者,其中209例(4.96%)合并TOS。其中,55例(26%)接受了第一肋切除术。合并TOS的患者比未合并TOS的患者更年轻,合并症更少。接受手术的TOS患者与未接受手术的患者之间没有差异。在抗凝治疗期间,合并TOS的患者VTE复发率低于未合并TOS的患者,但差异无统计学意义(风险比[HR]:0.46;95%置信区间:0.14-1.12),出血率更低(HR:0.16;95%置信区间:0.01-0.83)。没有合并TOS的患者发生肺栓塞或死亡。接受手术的TOS患者在一年后出现PTS症状(优势比[OR]:0.21;95%置信区间:0.06-0.68)或体征(OR:0.11;95%置信区间:0.02-0.42)的比例低于未接受手术的患者。在两年时,症状(OR:0.25;95%置信区间:0.06-0.94)和体征(OR:0.04;95%置信区间:0.002-0.33)的差异仍然存在。
合并UEDVT和TOS的患者比未合并者更年轻,合并症更少。第一肋手术切除与一两年后发生PTS的患者比例较低有关。